Amendments To The Cabinet Of Ministers On 31 October 2006, Regulations No 899 "outpatient Treatments And Medicines For The Purchase Of Medical Equipment For The Refund Order"

Original Language Title: Grozījumi Ministru kabineta 2006.gada 31.oktobra noteikumos Nr.899 "Ambulatorajai ārstēšanai paredzēto zāļu un medicīnisko ierīču iegādes izdevumu kompensācijas kārtība"

Read the untranslated law here: https://www.vestnesis.lv/ta/id/155231

Cabinet of Ministers Regulations No. 219 in Riga in 2007 (March 27. No 21 24) amendments to the Cabinet of Ministers on 31 October 2006, regulations No 899 "Outpatient treatments and medicines for the purchase of medical equipment for the refund order" Issued in accordance with article 5 of the law on Pharmacy's paragraph 20 1. make a Cabinet of 31 October 2006, regulations No 899 "Outpatient treatments and medicines for the purchase of medical equipment for the refund order" (Latvian journal, 2006, 180. no) the following amendments: 1. to supplement 27 to the second sentence by the following : "The rest of the eligible list of medicines and the drug costs with a parallel imported medicinal product (imported) costs does not compare."; 1.2. to supplement the rules with 32.3 points following below: "if they have a combined 32.3. the composition of the medicinal product, containing the existing drug generic names are included in the list of eligible medicines and medicinal products has not been established in clinical studies of the combined benefits of medicines of therapeutic efficacy and adverse reactions, compared to the existing separate easy-to-use medicinal products. '; 1.3. deleting subparagraph; 25.7. 1.4. the express 94 and 95 of the following paragraph: "94. This rule 57.2. in the case referred to in subparagraph health compulsory insurance State Agency shall take a decision on the medication or medical equipment the purchase of 100% of compensation, except that rule 100.1 referred cases. 95. This rule 92.2. in the case referred to in subparagraph health compulsory insurance State Agency shall take a decision on the drug or medical device reimbursement of expenses of the acquisition, this provision defined in annex 1, except for this provision to cases referred to in paragraph 100.1. "; 1.5. to supplement the provisions of the following paragraph 100.1:100.1 "If the proposed expenditure exceed this provision referred to in paragraph 100, the health compulsory insurance State agency decision on compensation of expenses refund stated on the packaging of medicinal products one. The difference between the price and the packaging of medicines health compulsory insurance State Agency specified in the decision of the amount of compensation payable by the patient when medication pharmacy. "; 1.6. the express section 102.6. as follows: "102.6. in accordance with the regulations on the procedure for the classification of medicinal products medicinal products classified as non-prescription drugs, other than that necessary for patients with cystic fibrosis life function."; 1.7. to supplement annex 1 with the bottom point 3.11 as follows: "3.11 other clotting factors inherited lack D 100 with diagnosis code 68.2 D 68.2 included diagnoses" inherited clotting factor deficiencies of other "bottom" factor VII the diagnosis deficit "1.8. make 8.18. of annex 1 section as follows: 8.18. Cystic Fibrosis" E 84.0; E 84.1; E 84.8; E 100 ' 2.84.9 rules enter into force by 1 April 2007.
Prime Minister a. Halloween Health Minister v. Veldr MC